Ceva price target lowered to $29 from $32 at Barclays

Barclays analyst Tavy Rosner lowered the firm’s price target on Ceva to $29 from $32 and keeps an Overweight rating on the shares. The company’s Q2 results were impacted by unexpected delays in licensing deal closures, but management was constructive around new deals and the underlying strength of the business, the analyst tells investors in a research note. The firm reduced estimates following the quarter.